Next Article in Journal
Evaluation of Safety and Immunogenicity of BNT162B2 mRNA COVID-19 Vaccine in IBD Pediatric Population with Distinct Immune Suppressive Regimens
Next Article in Special Issue
COVID-19 Vaccination and Medical Liability: An International Perspective in 18 Countries
Previous Article in Journal
Early Impact of SARS-CoV-2 Pandemic on Immunization Services in Nigeria
Previous Article in Special Issue
Spread of COVID-19 Infection in Long-Term Care Facilities of Trieste (Italy) during the Pre-Vaccination Era, Integrating Findings of 41 Forensic Autopsies with Geriatric Comorbidity Index as a Valid Option for the Assessment of Strength of Causation
 
 
Perspective

Article Versions Notes

Vaccines 2022, 10(7), 1108; https://doi.org/10.3390/vaccines10071108
Action Date Notes Link
article xml file uploaded 11 July 2022 14:22 CEST Original file -
article xml uploaded. 11 July 2022 14:22 CEST Update https://www.mdpi.com/2076-393X/10/7/1108/xml
article pdf uploaded. 11 July 2022 14:22 CEST Version of Record https://www.mdpi.com/2076-393X/10/7/1108/pdf
article html file updated 11 July 2022 14:24 CEST Original file -
article html file updated 13 August 2022 01:12 CEST Update https://www.mdpi.com/2076-393X/10/7/1108/html
Back to TopTop